搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Schizosaccharomyces pombe CTD kinase subunit beta (lsc1) CSB-YP530083SXV
CSB-EP530083SXV
CSB-BP530083SXV
CSB-MP530083SXV
CSB-EP530083SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Putative uncharacterized hydrolase C1020.07 (SPCC1020.07) CSB-YP530084SXV
CSB-EP530084SXV
CSB-BP530084SXV
CSB-MP530084SXV
CSB-EP530084SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe 37S ribosomal protein subunit sws2, mitochondrial (sws2) CSB-YP530085SXV
CSB-EP530085SXV
CSB-BP530085SXV
CSB-MP530085SXV
CSB-EP530085SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Uncharacterized protein C320.06 (SPCC320.06) CSB-YP530086SXV
CSB-EP530086SXV
CSB-BP530086SXV
CSB-MP530086SXV
CSB-EP530086SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Uncharacterized protein C364.01 (SPCC364.01) CSB-YP530087SXV
CSB-EP530087SXV
CSB-BP530087SXV
CSB-MP530087SXV
CSB-EP530087SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Pre-mRNA-splicing factor slt11 (cwf5) CSB-YP530088SXV
CSB-EP530088SXV
CSB-BP530088SXV
CSB-MP530088SXV
CSB-EP530088SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Peroxisomal membrane protein pex32 (pex32), partial CSB-YP530089SXV1
CSB-EP530089SXV1
CSB-BP530089SXV1
CSB-MP530089SXV1
CSB-EP530089SXV1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Uncharacterized amino-acid permease C794.03 (SPCC794.03), partial CSB-YP530090SXV
CSB-EP530090SXV
CSB-BP530090SXV
CSB-MP530090SXV
CSB-EP530090SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Probable UTP--glucose-1-phosphate uridylyltransferase (SPCC794.10) CSB-YP530091SXV
CSB-EP530091SXV
CSB-BP530091SXV
CSB-MP530091SXV
CSB-EP530091SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Putative voltage-gated potassium channel subunit beta (SPCC965.06) CSB-YP530092SXV
CSB-EP530092SXV
CSB-BP530092SXV
CSB-MP530092SXV
CSB-EP530092SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Uncharacterized dipeptidase C965.12 (SPCC965.12) CSB-YP530093SXV
CSB-EP530093SXV
CSB-BP530093SXV
CSB-MP530093SXV
CSB-EP530093SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant 1,4-beta-D-glucan cellobiohydrolase B (cbhB), partial CSB-YP530094DOV
CSB-EP530094DOV
CSB-BP530094DOV
CSB-MP530094DOV
CSB-EP530094DOV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Probable heat shock protein ssa2 (ssa2), partial CSB-YP530095SXV
CSB-EP530095SXV
CSB-BP530095SXV
CSB-MP530095SXV
CSB-EP530095SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe 40S ribosomal protein S24-B (rps24b) CSB-YP530096SXV
CSB-EP530096SXV
CSB-BP530096SXV
CSB-MP530096SXV
CSB-EP530096SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Penicillium purpurogenum Acetylxylan esterase 2 (axe-2) CSB-YP530097ETN
CSB-EP530097ETN
CSB-BP530097ETN
CSB-MP530097ETN
CSB-EP530097ETN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Penicillium expansum Polygalacturonase (PEPG1) CSB-YP530098ETI
CSB-EP530098ETI
CSB-BP530098ETI
CSB-MP530098ETI
CSB-EP530098ETI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Colletotrichum gloeosporioides Pectate lyase B (PLB) CSB-YP530099DVE
CSB-EP530099DVE
CSB-BP530099DVE
CSB-MP530099DVE
CSB-EP530099DVE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Thermomyces lanuginosus Lipase (LIP) CSB-YP530100TNC
CSB-EP530100TNC
CSB-BP530100TNC
CSB-MP530100TNC
CSB-EP530100TNC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neurospora crassa DNA-binding protein cre-1 (cre-1) CSB-YP530101NHA
CSB-EP530101NHA
CSB-BP530101NHA
CSB-MP530101NHA
CSB-EP530101NHA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pichia angusta Dihydroxyacetone kinase (DAK), partial CSB-YP530102EVQ
CSB-EP530102EVQ
CSB-BP530102EVQ
CSB-MP530102EVQ
CSB-EP530102EVQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>